Hyperfine (NASDAQ:HYPR) Announces Earnings Results

Key Points

• Hyperfine (NASDAQ:HYPR) reported a quarterly earnings per share of ($0.12), matching analysts' expectations, but posted a negative return on equity of 74.19%.
• The company's stock increased by 5.8% to $1.27 following the earnings report, with a market capitalization of approximately $98.84 million.
• Analysts have mixed views on Hyperfine, with Wells Fargo lowering its price target from $1.29 to $0.68, while B. Riley maintained a "buy" rating.

Hyperfine (NASDAQ:HYPR - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.12) earnings per share for the quarter, meeting the consensus estimate of ($0.12), Zacks reports. Hyperfine had a negative return on equity of 74.19% and a negative net margin of 343.42%. Hyperfine updated its FY 2025 guidance to EPS.

Hyperfine Stock Up 5.8%

NASDAQ:HYPR traded up $0.07 on Wednesday, hitting $1.27. The stock had a trading volume of 422,837 shares, compared to its average volume of 1,454,422. The stock has a market cap of $98.84 million, a price-to-earnings ratio of -2.35 and a beta of 1.06. The company has a fifty day moving average price of $0.89 and a two-hundred day moving average price of $0.87. Hyperfine has a 1-year low of $0.53 and a 1-year high of $1.90.

Wall Street Analyst Weigh In

HYPR has been the topic of a number of research analyst reports. Wells Fargo & Company dropped their target price on shares of Hyperfine from $1.29 to $0.68 and set an "equal weight" rating on the stock in a research note on Wednesday, May 14th. B. Riley restated a "buy" rating on shares of Hyperfine in a research note on Tuesday, June 3rd.

About Hyperfine

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.